Hidradenitis Suppurativa Wound Care
- Conditions
- Hidradenitis Suppurativa (HS)
- Registration Number
- NCT04354012
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
The objective of this case series is to monitor time and outcome of healing of wounds associated with HS using Endoform \[ovine forestomach\], Hydrofera Blue \[methylene blue and gentian violet\], and Hypafix tape. a combination methylene blue, gentian violet, and ovine forestomach wound care product.
- Detailed Description
Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory disease most frequently affecting the axilla, groin, and inframammary regions. Symptoms include nodules, abscesses, sinus tract formation, malodorous drainage, and scarring. These symptoms interfere with everyday activities, which can lead to social embarrassment and isolation. Patients with HS suffer psychological effects, such as increased levels of anxiety, depression, and loneliness, which impair quality of life.
Patients suffer with the burden of at home wound care for recurrent, draining nodules. Persistent lesions affect patients' lives by limiting their daily activities. Currently, patients are instructed to use gauze and tape to cover draining wounds, but this can be insufficient and difficult due to the nature and location of lesions associated with HS. Patients suffer with caring for their wounds, which can lead to frustration. Providing patients with a standard wound care regimen to take home can improve patients' quality of life and control of their disease. General recommendations for wound care in HS patients are limited. Improvements in the standard of care for wound management in HS are needed to aid patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
- Individuals with hidradenitis suppurativa with non-healing wounds or draining abscesses/nodules
- Individuals over 18 years of age
- Individuals younger than 18 years of age
- Individuals without a diagnosis of HS
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Percent Change in Wound Size Measure from Baseline to week 8 Asses the percent healing that occurs over 8 weeks of follow-up using Endoform and Hydrofera Blue products
- Secondary Outcome Measures
Name Time Method Change in Pain Assessment Scores Change from week 4 to week 8 Assess changes in patient reported pain via Numerical Rating Scale of Pain (NRS) a scale using a number from 0 to 10 where 0 is no pain or hurt and 10 is the most or worst pain.
Trial Locations
- Locations (1)
Wake Forest Health Sciences Dermatology
🇺🇸Winston-Salem, North Carolina, United States
Wake Forest Health Sciences Dermatology🇺🇸Winston-Salem, North Carolina, United States